IRADIMED CORPORATION (IRMD)

IRADIMED CORPORATION Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 3, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	1,037	1,238	697	598	356	570
Market Cap Growth	4.13%	77.54%	16.49%	68.32%	-37.66%	103.87%
Enterprise Value	974	1,181	646	554	302	514
Last Close Price	79.42	96.65	53.79	45.98	26.22	41.97

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 3, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	43.38	55.05	36.24	34.81	27.71	61.16
Forward PE	36.08	54.04	34.59	33.91	26.07	65.08
PS Ratio	11.50	14.77	9.52	9.13	6.67	13.64
PB Ratio	9.54	13.08	8.03	8.38	4.83	7.90
P/TBV Ratio	9.97	13.56	8.33	8.69	4.97	8.03
P/FCF Ratio	39.31	72.02	39.56	99.33	38.56	52.93
P/OCF Ratio	37.84	49.61	27.20	44.44	35.40	50.66
PEG Ratio	2.94	0.77	0.77	0.77	0.77	0.77

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 3, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	10.79	14.09	8.81	8.45	5.67	12.28
EV/EBITDA Ratio	31.59	43.24	28.34	26.62	18.54	45.75
EV/EBIT Ratio	33.41	45.17	29.39	27.64	19.34	52.31
EV/FCF Ratio	36.89	68.73	36.64	91.92	32.78	47.66

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 3, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	-	-	0	0.03	0.03	0.03
Debt / EBITDA Ratio	-	-	0.00	0.10	0.13	0.21
Debt / FCF Ratio	-	-	0	0.34	0.24	0.23
Net Debt / Equity Ratio	-0.59	-0.54	-0.60	-0.67	-0.76	-0.83
Net Debt / EBITDA Ratio	-2.07	-1.87	-2.29	-2.29	-3.42	-5.35
Net Debt / FCF Ratio	-2.42	-2.98	-2.96	-7.92	-6.05	-5.57
Asset Turnover	0.76	0.81	0.77	0.74	0.63	0.54
Inventory Turnover	1.74	1.77	1.46	1.69	2.49	2.37
Quick Ratio	7.46	6.37	7.38	3.80	8.33	9.91
Current Ratio	8.99	7.98	8.84	4.66	9.06	11.18
Return on Equity (ROE)	23.42%	24.78%	24.31%	23.70%	17.59%	13.96%
Return on Assets (ROA)	15.30%	15.78%	14.41%	14.10%	11.60%	7.97%
Return on Invested Capital (ROIC)	51.83%	53.11%	59.72%	76.15%	82.40%	76.68%
Return on Capital Employed (ROCE)	26.10%	26.50%	24.50%	26.40%	20.30%	12.90%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 3, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	2.31%	1.82%	2.76%	2.87%	3.61%	1.64%
FCF Yield	2.54%	1.39%	2.53%	1.01%	2.59%	1.89%
Dividend Yield	0.99%	0.73%	0.86%	0.32%	-	-
Payout Ratio	42.79%	66.90%	71.11%	76.91%	97.90%	-
Buyback Yield / Dilution	-0.26%	-0.55%	-0.48%	-0.69%	-0.36%	-1.21%
Total Shareholder Return	0.73%	0.18%	0.37%	-0.37%	-0.36%	-1.21%

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error